[Federal Register Volume 84, Number 146 (Tuesday, July 30, 2019)]
[Notices]
[Pages 36947-36948]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16165]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Southern Ohio 
Correctional Facility

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration or the proposed authorization to 
import on or before August 29, 2019. Such persons may also file a 
written request for a hearing on the application for registration and 
for authorization to import on or before August 29, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for hearing a should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: 
    Pursuant to 21 U.S.C. 958(i), prior to issuing a regulation under 
21 U.S.C. 952(a)(2)(B) authorizing the importation of a controlled 
substance in schedule I or II, DEA is required to provide manufacturers 
holding registrations for the bulk manufacture of the substance an 
opportunity for a hearing. Additionally, pursuant to 21 CFR 1301.34(a), 
DEA shall, upon the filing of an application for registration to import 
a controlled substance in schedule I or II under 21 U.S.C. 
952(a)(2)(B), provide notice and the opportunity to request a hearing 
to manufacturers holding registrations for the bulk manufacture of the 
substance and to applicants for such registrations.

[[Page 36948]]

    Therefore, in accordance with 21 U.S.C. 958(i) and 21 CFR 
1301.34(a), this is notice that on January 31, 2017, Southern Ohio 
Correctional Facility, 1724 State Route 728, Lucasville, Ohio 45699, 
applied to be registered as an importer of Pentobarbital (2270), a 
basic class of controlled substance listed in schedule II.
    The facility intends to import the above-listed controlled 
substance for legitimate use. This particular controlled substance is 
not available for the intended legitimate use within the current 
domestic supply of the United States.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture this basic class of controlled 
substance may file comments or objections to the issuance of the 
proposed registration or to the authorization of this importation, and 
may, at the same time, file a written request for a hearing. Any such 
comments, objections, or hearing requests should be addressed as 
described above.

    Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-16165 Filed 7-29-19; 8:45 am]
 BILLING CODE 4410-09-P